We are compliant to global standards
Chieron executive and operational teams understand the complex issues associated with regulatory agencies and assists in the approval of each complex API by analyzing the latest regulatory trends, quality requirements through active monitoring and proactive assessment of potential risks. Chieron ’s products meet the rigorous Japanese pharmacopeia standards, providing a unique advantage to clients. Additionally, the company’s streamlined regulatory strategy, which includes filing a single Drug Master File (DMF) across multiple geographies, simplifies the approval process and enhances market accessibility.
Chieron is a USFDA, EDQM, PMDA, KFDA Approved Site . We are tirelessly pursuing approvals from ANVISA and the Chinese cFDA for our key products.
